Creagan ET - Search Results

1

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

Creagan ET, Dalton RJ, Ahmann DL, Jung SH, Morton RF, Langdon RM Jr, Kugler J, Rodrigue LJ. Creagan ET, et al. J Clin Oncol. 1995 Nov;13(11):2776-83. doi: 10.1200/JCO.1995.13.11.2776. J Clin Oncol. 1995. PMID: 7595738 Clinical Trial.

2

Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma.

Markovic S, Suman VJ, Dalton RJ, Woods JE, Fitzgibbons RJ Jr, Wold LE, Buckner JC, Kugler JW, Mailliard JA, Rowland KM, Krook JE, Brown DW, Tirona MT, Creagan ET. Markovic S, et al. Among authors: creagan et. Am J Clin Oncol. 2002 Dec;25(6):552-6. doi: 10.1097/00000421-200212000-00003. Am J Clin Oncol. 2002. PMID: 12477996 Clinical Trial.

3

Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma.

Feldman ER, Creagan ET, Schaid DJ, Ahmann DL. Feldman ER, et al. Among authors: creagan et. Am J Clin Oncol. 1992 Jun;15(3):256-9. doi: 10.1097/00000421-199206000-00015. Am J Clin Oncol. 1992. PMID: 1590281 Clinical Trial.

4

Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma.

Morton RF, Creagan ET, Schaid DJ, Kardinal CG, McCormack GW, McHale MS, Wiesenfeld M. Morton RF, et al. Among authors: creagan et. Am J Clin Oncol. 1991 Apr;14(2):152-5. doi: 10.1097/00000421-199104000-00011. Am J Clin Oncol. 1991. PMID: 2028922

5

Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanoma.

Creagan ET, Long HJ, Ahmann DL, Schaid DJ. Creagan ET, et al. Am J Clin Oncol. 1990 Jun;13(3):218-20. doi: 10.1097/00000421-199006000-00008. Am J Clin Oncol. 1990. PMID: 2111969

6

Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations.

Creagan ET, Schaid DJ, Ahmann DL, Frytak S. Creagan ET, et al. J Invest Dermatol. 1990 Dec;95(6 Suppl):188S-192S. doi: 10.1111/1523-1747.ep12875512. J Invest Dermatol. 1990. PMID: 2124246 Free article. Clinical Trial.

7

Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders.

Creagan ET, Schaid DJ, Ahmann DL, Frytak S. Creagan ET, et al. Am J Clin Oncol. 1988 Dec;11(6):652-9. doi: 10.1097/00000421-198812000-00013. Am J Clin Oncol. 1988. PMID: 3142248

8

A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma.

Creagan ET, Loprinzi CL, Ahmann DL, Schaid DJ. Creagan ET, et al. Cancer. 1988 Dec 15;62(12):2472-4. doi: 10.1002/1097-0142(19881215)62:12<2472::aid-cncr2820621203>3.0.co;2-g. Cancer. 1988. PMID: 3142675

9

Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma.

Creagan ET, Ahmann DL, Green SJ, Long HJ, Frytak S, Itri LM. Creagan ET, et al. J Clin Oncol. 1985 Jul;3(7):977-81. doi: 10.1200/JCO.1985.3.7.977. J Clin Oncol. 1985. PMID: 4020408

10

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.

Creagan ET, Ahmann DL, Green SJ, Long HJ, Frytak S, O'Fallon JR, Itri LM. Creagan ET, et al. J Clin Oncol. 1984 Sep;2(9):1002-5. doi: 10.1200/JCO.1984.2.9.1002. J Clin Oncol. 1984. PMID: 6470751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page